Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ESSA Pharma Inc (EPIX)
NASDAQ:EPIX
ESSA Pharma (EPIX) Stock Price & Analysis
222 Followers
EPIX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.58 - $11.67
Previous Close$6.74
Volume2.45K
Average Volume (3M)78.79K
Market Cap
$295.95M
Enterprise Value$156.42M
Total Cash (Recent Filing)$142.12M
Total Debt (Recent Filing)$374.83K
Price to Earnings (P/E)-11.5
Beta1.91
Next Earnings
Aug 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.58
Shares Outstanding44,238,147
10 Day Avg. Volume53,452
30 Day Avg. Volume78,792
Standard Deviation0.26
R-Squared0.13
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)2.14
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-11.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-13.48
Forecast
1Y Price Target
$18.00Price Target Upside169.06% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
ESSA Pharma News
PremiumCompany Announcements
ESSA Pharma Shareholders Show Strong Support
PremiumCompany Announcements
ESSA Pharma Reports Progress in Masofaniten Study
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EPIX FAQ
What was ESSA Pharma Inc’s price range in the past 12 months?
ESSA Pharma Inc lowest stock price was $2.58 and its highest was $11.67 in the past 12 months.
What is ESSA Pharma Inc’s market cap?
Currently, no data Available
When is ESSA Pharma Inc’s upcoming earnings report date?
ESSA Pharma Inc’s upcoming earnings report date is Aug 13, 2024 which is in 95 days.
How were ESSA Pharma Inc’s earnings last quarter?
Currently, no data Available
Is ESSA Pharma Inc overvalued?
According to Wall Street analysts ESSA Pharma Inc’s price is currently Undervalued.
Does ESSA Pharma Inc pay dividends?
ESSA Pharma Inc does not currently pay dividends.
What is ESSA Pharma Inc’s EPS estimate?
ESSA Pharma Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ESSA Pharma Inc have?
ESSA Pharma Inc has 44,238,148 shares outstanding.
What happened to ESSA Pharma Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ESSA Pharma Inc?
Among the largest hedge funds holding ESSA Pharma Inc’s share is Driehaus Capital Management LLC. It holds ESSA Pharma Inc’s shares valued at N/A.
---
ESSA Pharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$18.00 (169.06% Upside)
$18.00 (169.06% Upside)
Blogger Sentiment
Bullish
EPIX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 28.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $18.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.8%
Last 30 Days ▼ 10.0%
Last 30 Days ▼ 10.0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
130.82%
12-Months-Change
Fundamentals
Return on Equity
-17.05%
Trailing 12-Months
Asset Growth
-12.43%
Trailing 12-Months
Company Description
ESSA Pharma Inc
ESSA Pharma, Inc. engages in the development of small molecule drugs for prostate cancer. It focuses on producing drugs which selectively block the amino-terminal domain (NTD) of the androgen receptor (AR), potentially overcoming the known AR-dependent resistance mechanisms of castration-resistant prostate cancer (CRPC), and providing CRPC patients with the potential for increased progression-free and overall survival. The company was founded by Marianne D. Sadar and Raymond J. Andersen on January 6, 2009 and is headquartered in Vancouver, Canada.
---
EPIX Stock 12 Month Forecast
Average Price Target
$18.00
▲(169.06% Upside)
Technical Analysis
Best Analysts Covering EPIX
1 Year
1 Year Success Rate
4/5 ratings generated profit
1 Year Average Return
+171.30%
reiterated a buy rating 7 months ago
Copying David Martin PhD's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +171.30% per trade.
---